Serum leptin concentration in patients with type 2 diabetes

1. Anderlová K. et. al.: The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol. Res., 55(3), 277, 2006.10.33549/physiolres.93077916083306Search in Google Scholar

2. Bays H.E.: Adiposopathy is “sick fat” a cardiovascular disease? J. Am. Coll. Cardiol., 57(25), 2461, 2011.10.1016/j.jacc.2011.02.03821679848Search in Google Scholar

3. Blüher M., Mantzoros C.S.: From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism, 64(1), 131, 2015.10.1016/j.metabol.2014.10.01625497344Search in Google Scholar

4. Chen G.C., Qin L.Q., Ye J.K.: Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 15(2), 134, 2014.10.1111/obr.1208824102863Search in Google Scholar

5. Chen K. et. al.: Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med., 12(4), 425, 2006.10.1038/nm137216582918Search in Google Scholar

6. Correia M.L., Rahmouni K.: Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes. Metab., 8(6), 603, 2006.10.1111/j.1463-1326.2005.00562.x17026484Search in Google Scholar

7. Dardeno T.A. et. al.: Leptin in human physiology and therapeutics. Front Neuroendocrinol., 31(3), 377, 2010.10.1016/j.yfrne.2010.06.002291673520600241Search in Google Scholar

8. Denroche H.C., Huynh F.K., Kieffer T.J.: The role of leptin in glucose homeostasis. J. Diabetes Investig., 3(2), 115, 2012.10.1111/j.2040-1124.2012.00203.x402072824843554Search in Google Scholar

9. Esteghamati A. et. al.: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab. Syndr. Relat. Disord. 7(5), 447, 2009.10.1089/met.2008.010019419266Search in Google Scholar

10. Esteghamati A. et. al.: Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistant and obesity. Diabetes Res. Clin. Pract., 91(2), 154, 2011.10.1016/j.diabres.2010.11.00321122936Search in Google Scholar

11. Friedewald W.T., Levy R.I., Fredrickson D.S.: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18(6), 499, 1972.10.1093/clinchem/18.6.499Search in Google Scholar

12. Gui Y., Silha J.V., Murphy L.J.: Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res., 12(9), 1481, 2004.10.1038/oby.2004.18515483213Search in Google Scholar

13. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab,. 89(6), 2548, 2004.10.1210/jc.2004-039515181022Search in Google Scholar

14. Lee J.M. et. al.: The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. Int. Med. Res., 37(6), 1803, 2009.10.1177/14732300090370061620146878Search in Google Scholar

15. Levey A.S. et. al.: Using standardized serum creatinine values in the modification of diet in the renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med., 145(4), 247, 2006.10.7326/0003-4819-145-4-200608150-0000416908915Search in Google Scholar

16. Ley S.H. et. al.: Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care, 31(7), 1410, 2008.10.2337/dc08-0036245366418339973Search in Google Scholar

17. Malecha-Jedraszek A. et. al.: Concentration of adiponectin in relation to insulin resistance in patients with type 2 diabetes. Ann. UMCS Sect. DDD, 24 (4), 73, 2011.Search in Google Scholar

18. Martos-Moreno G.Á. et. al.: Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring),18(12), 2288, 2010.10.1038/oby.2010.6820339359Search in Google Scholar

19. Matthews D.R. et. al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412, 1985.10.1007/BF002808833899825Search in Google Scholar

20. Menon V. et. al.: Factors associated with serum leptin in patients with chronic kidney disease. Clin. Nephrol., 61(3), 163, 2004.10.5414/CNP61163Search in Google Scholar

21. Olstad R. et. al.: Leptin in the General Population, Differences in Sex Hormones, Blood Lipids, Gender and Life Style Characteristics. The Open Behavioral Science Journal, 5, 8, 2011.10.2174/1874230001105010008Search in Google Scholar

22. Park H.K., Ahima R.S.: Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism, 64(1), 24, 2015.10.1016/j.metabol.2014.08.004426789825199978Search in Google Scholar

23. Paz-Filho G. et. al.: Leptin: molecular mechanisms, systemic proinflammatory effects, and clinical implications. Arq. Bras. Endocrinol. Metabol., 56(9), 597, 2012.10.1590/S0004-2730201200090000123329181Search in Google Scholar

24. Saginova E.A. et. al.: The role of leptin, adiponectin and insulinresistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients. Ter. Arkh., 83(6), 47, 2011.Search in Google Scholar

25. Sáinz N. et. al.: Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism, 64(1), 35, 2015.10.1016/j.metabol.2014.10.01525497342Search in Google Scholar

26. Silha J.V. et. al.: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol., 149(4), 331, 2003.10.1530/eje.0.149033114514348Search in Google Scholar

27. Söderberg S. et. al.: Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int. J. Obes. (Lond)., 31(7), 1126, 2007.10.1038/sj.ijo.080356117325688Search in Google Scholar

28. Sun Q. et. al.: Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes, 2010; 611, 59(3).Search in Google Scholar

29. Tokuyama Y. et. al.: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 56(5), 693, 2007.10.1016/j.metabol.2006.12.01917445546Search in Google Scholar

30. Wang H., Luo W., Eitzman D.T.: Leptin in thrombosis and atherosclerosis. Curr. Pharm. Des., 20(4), 641, 2014.10.2174/1381612811319999001523688009Search in Google Scholar

31. Wannamethee S.G. et. al.: Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 30(5), 1200, 2007.10.2337/dc06-241617322479Search in Google Scholar

32. Wannamethee S.G. et. al.: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis, 191(2), 18, 2007.10.1016/j.atherosclerosis.2006.04.01216712853Search in Google Scholar

33. Welsh P. et. al.: Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care, 32(2), 308, 2009.10.2337/dc08-1458262869919001191Search in Google Scholar

34. Wolf G., Ziyadeh F.N.: Leptin and renal fibrosis. Contrib. Nephrol., 151, 175, 2006.Search in Google Scholar

35. World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation, Genewa 1997.Search in Google Scholar

36. Zhou Y., Rui L.: Leptin signaling and leptin resistance. Front Med., 7(2), 207, 2013.10.1007/s11684-013-0263-5Search in Google Scholar

37. Zimmet P., Alberti K.G., Serrano Ríos M.: A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev. Esp. Cardiol., 58(12), 1371, 2005.10.1016/S1885-5857(06)60742-1Search in Google Scholar

38. Zuo H. et. al.: Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One, 8(1), 1, 2013.10.1371/journal.pone.0054615355175923349940Search in Google Scholar